People In The News | GenomeWeb

NEW YORK (GenomeWeb) – The ACMG Foundation for Genetic and Genomic Medicine has named four new directors to its board of directors including Evan Jones, Matthew Rabinowitz, James Bartley, and David Whiteman.

Jones was co-founder, chairman, and CEO of Digene, and he currently is chairman and CEO of OpGen and a board member at Fluidigm, Foundation Medicine, and Veracyte. He also previously was chairman of Signature Genomic Laboratories before it was sold to PerkinElmer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.